ASCO grants $50,000 to societies for outreach projects

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 18 No 5
Volume 18
Issue 5

ORLANDO, Fla.-ASCO has awarded $10,000 grants to five state projects. The recipients will be recognized at the State Affiliates’ Reception at ASCO 2009.

ORLANDO, Fla.-ASCO has awarded $10,000 grants to five state projects. The recipients will be recognized at the State Affiliates' Reception at ASCO 2009.

The 2009 winners and their projects include:

• Denali Oncology Group: Based in Anchorage, Alaska, the group will create a web site of cancer-related resource information for Alaskan physicians, their patients, and families. The site will include information on available clinical trials and an online database of society members who practice in the state.

• Georgia Society of Clinical Oncology: Along with the Georgia Cancer Coalition, the society will identify existing resources that offer patient navigation services. They also will host a stakeholders meeting to assess the need for a cancer patient navigator's association.

• Maryland/DC Society of Clinical Oncology: The society will develop an online social networking website to provide opportunities for collaboration among its members. Specifically, the site will help oncologists in Maryland and Washington, DC, share information on clinical trials, research findings, and other oncology-related topics.

• New York State Society of Medical Oncologists & Hematologists: The society will develop and promote an outreach project to identify oncology/hematology practice issues that adversely affect patient access to cancer care, including promoting communication between hematologists and oncologists and encouraging clinical research.

• Northern New England Clinical Oncology Society: The society will conduct a study to determine barriers to clinical trials participation. The study will focus on whether the cost of participation contributes to an individual's decision to forego trial participation.

Related Videos
Positive margin rates have not appeared to improve for patients with cancer undergoing surgical care based on several prior studies.
Investigators must continue to explore the space for lisocabtagene maraleucel in mantle cell lymphoma, according to Manali Kamdar, MD.
Those with CML should discuss adverse effects such as nausea or fatigue with their providers to help optimize their quality of life during treatment.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Patients with CML can become an active part of their treatment plan by discussing any questions that come to mind with their providers.
A panel of 4 experts on multiple myeloma
Video 1 - 4 KOLs are featured in "Treating Patients Referred to Academic Centers for CAR T"
Video 1 - 4 KOLs are featured in "Identifying Potential Candidates for CAR T-Cell Therapy"
Related Content